Results 71 to 80 of about 5,814 (145)

Case Report: Neurofilament light chain in the follow up of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with ocrelizumab

Frontiers in Pharmacology
Progressive multifocal leukoencephalopathy (PML) results from the reactivation of John Cunningham virus JC virus and is a rare complication of anti-CD20 drug therapy.
Raquel Piñar-Morales, Raquel Piñar-Morales, Raquel Calle-Calle, Maria Carrasco-Garcia, Cristina Davila-Arias, Luisa Maria Villar-Guimerans, Francisco J. Barrero Hernandez, Francisco J. Barrero Hernandez   +7 more
doaj   +1 more source

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

Fluids and Barriers of the CNS, 2019
Progressive multifocal leukoencephalopathy (PML), caused by infection with John Cunningham polyoma virus (JCPyV) in immune-compromised patients, is a serious demyelinating disease of the central nervous system.
Nora Möhn, Yi Luo, Thomas Skripuletz, Philipp Schwenkenbecher, Inga Zerr, Peter Lange, Martin Stangel   +6 more
doaj   +1 more source

Progressive multifocal leukoencephalopathy caused by the John Cunningham virus: a case report

Revista de la Facultad de Medicina
Introduction: Progressive multifocal leukoencephalopathy (PML) is a demyelinating, multifactorial disease that can be caused by the John Cunningham virus (JCV) and occurs mainly in people with HIV/AIDS.
Dario Fernando Muñoz-Mora, Víctor Hugo Lozano-Fernández, Angie Katherine Uribe-Caldón   +2 more
doaj   +1 more source

Pediatric progressive multifocal leucoencephalopathy presenting with neuroregression in a child with newly diagnosed HIV

Current Medicine Research and Practice
Progressive multifocal leucoencephalopathy is a rare demyelinating condition of the central nervous system that results from infection with human polyomavirus 2 commonly referred to as the John Cunningham virus (JCV).
Payal Keswaani, Shreya Chauhan, Praveen Kumar   +2 more
doaj   +1 more source

Molecular Interplay of John Cunningham Virus with Interleukin 1 Beta in Colorectal Carcinomatous Tissues from a Group of Iraqi Patients. [PDF]

Arch Razi Inst, 2022
Muhsen M Ali Z, Ghaith Sachit H, Jaafar Hussein M, Mohammed Ali SH, Mohammed Al-Alwany SH, Khalil Hussein A.   +5 more
europepmc   +1 more source

Poster Session 2

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Leucoencefalopatía multifocal progresiva asociada al uso de Natalizumab en un paciente con esclerosis múltiple. Primer caso en Latinoamérica. Hospital de San José - Bogotá 2013

Acta Neurológica Colombiana, 2015
La Leucoencefalopatía Multifocal Progresiva (LMP) es una condición grave secundaria a la infección por virus John Cunningham (VJC) derivada de la deficiencia de inmunidad celular innata o adquirida.
Javier Darío Triana, Marco Reyes, Leonardo Hernández, Oscar Mendoza, Sergio A. Salgado, Gina Paola Becerra   +5 more
doaj  

Erratum to: High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis. [PDF]

J Clin Neurol, 2020
Kim SH, Kim Y, Jung JY, Park NY, Jang H, Hyun JW, Kim HJ.   +6 more
europepmc   +1 more source

Progressive Multifocal Leukoencephalopathy confined to the posterior fossa as the presenting manifestation of HIV in a paediatric patient

IDCases
Progressive Multifocal Leukoencephalopathy (PML), primarily affecting immunocompromised individuals due to the John Cunningham virus (JC), is common in HIV-positive adults but rare in paediatrics. We present a unique case of a 14-year-old female with PML
JF. Nshimiyimana, S. Onsongo
doaj   +1 more source

John Cunningham virus

, 2015
Bruno Di Muzio, Kang Wei Esther Lim, Daniel Bell   +2 more
openaire   +1 more source